In our study, we found that shRNA‐mediated CKS2 silencing could inhibit proliferation and induce G0/G1 phase arrest and cell apoptosis in BL and DLBCL cells by activating the p53 signaling pathway. This evidence concerns the gene CKS2 and diffuse large B-cell lymphoma.